About
Kevin Craig became Chief Medical Officer of atai Life Sciences in 2025, having joined in 2021 as Vice President and later Senior Vice President of Clinical Development, where he oversees clinical development, regulatory affairs, drug safety, biostatistics, and global clinical operations. He has more than 20 years of clinical experience with a focus on neuroscience pipelines, and previously held a faculty appointment at the University of Cambridge's Behavioral and Clinical Neuroscience Institute and worked at P1vital on imaging and cognitive biomarkers for early-phase psychiatry trials. He earned his medical degree from the University of Witwatersrand and an MPhil in Medical Science from the University of Cambridge, and is a member of the Royal College of Psychiatrists with accreditation in addiction and adult psychiatry.
Invests in
BiotechDigital HealthMental Health
Experience
- AtaiBeckleyChief Medical Officercurrent2025 — presentLondon Area, United Kingdom
- AtaiBeckleySVP, Clinical Development2023 — 2025London, England, United Kingdom
- AtaiBeckleyVice President, Clinical Development2021 — 2023London, England, United Kingdom
- Jazz PharmaceuticalsHead of Early Clinical Development2021London, England, United Kingdom
- GW Pharmaceuticals plcHead of Early Clinical Development2018 — 2021London, United Kingdom
- CovanceGlobal Head of Medical Science, Clinical Pharmacology2018London, United Kingdom
- CovanceSenior Medical Director, Early Clinical Services2016 — 2018United Kingdom
- CovanceSenior Medical Director, Neuroscience2014 — 2016Singapore
- CovanceMedical Director, Neuroscience2011 — 2014Maidenhead, United Kingdom
- Singapore-MIT Alliance for Research & Technology Innovation CenterAdvisory Board Member and Catalyst2014 — 2016Singapore
- P1vitalChief Medical Officer2010 — 2011Oxford, United Kingdom
- P1vitalMedical Director2008 — 2010
- University of CambridgeSenior Clinical Research Fellow2006 — 2008Cambridge, United Kingdom
- NHSPsychiatrist1999 — 2006
Education
- University of CambridgeMPhil, Medicine2004 — 2005
- Royal College of PsychiatristsMRCPsych, Board certified in adult psychiatry and addiction1999 — 2002
- University of the WitwatersrandBachelor of Medicine, Bachelor of Surgery - MBBS1990 — 1996
Skills & more
BiopharmaceuticalsInvestigational New Drug Application (IND)U.S. Food and Drug Administration (FDA)LeadershipResearch and Development (R&D)Medical Group ManagementPhase 1 patient studiesRare DiseasesCNS disordersRegulatory AffairsBiostatisticsDigital Therapeutics
+12 more
Portfolio ManagementStrategic ThinkingBusiness DevelopmentPsychiatryClinical TrialsNeuroscienceClinical ResearchClinical DevelopmentDrug DevelopmentNeuropharmacologyBiomarkersMedicineFrom Kevin's professional profile.
Colleagues at atai Life Sciences
Amir Kalali
Director at atai Life Sciences
Andrea Heslin Smiley
Director at atai Life Sciences
Anne Johnson
Chief Accounting Officer at atai Life Sciences
Christian Angermayer
Founder and Chairman of the Board at atai Life Sciences
Gerd Kochendoerfer
Chief Operating Officer at atai Life Sciences
Glenn Short
Chief Scientific Officer at atai Life Sciences
John Hoffman
Director at atai Life Sciences
Laurent Fischer
Director at atai Life Sciences
Frequently asked questions
- Who is Kevin Craig?
- Kevin Craig became Chief Medical Officer of atai Life Sciences in 2025, having joined in 2021 as Vice President and later Senior Vice President of Clinical Development, where he oversees clinical development, regulatory affairs, drug safety, biostatistics, and global clinical operations. He has more than 20 years of clinical experience with a focus on neuroscience pipelines, and previously held a faculty appointment at the University of Cambridge's Behavioral and Clinical Neuroscience Institute and worked at P1vital on imaging and cognitive biomarkers for early-phase psychiatry trials. He earned his medical degree from the University of Witwatersrand and an MPhil in Medical Science from the University of Cambridge, and is a member of the Royal College of Psychiatrists with accreditation in addiction and adult psychiatry.
- Where does Kevin Craig work?
- Kevin Craig is Chief Medical Officer at atai Life Sciences.
- What does Kevin Craig invest in?
- Kevin Craig invests in Biotech, Digital Health, Mental Health.
- Where did Kevin Craig go to school?
- Kevin Craig studied at University of Cambridge (MPhil, Medicine); Royal College of Psychiatrists (MRCPsych, Board certified in adult psychiatry and addiction); University of the Witwatersrand (Bachelor of Medicine, Bachelor of Surgery - MBBS).
Same school
Also attended University of Cambridge859
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 853 more
Also attended University of the Witwatersrand70
David FrankelSeed Stage Venture Capital in the United StatesThomasGeneral Partner at Acadian Ventures Management, LlcDaniel SassAssociate at aMoonDavid EsraAnalyst at aMoonIlian IlievChief Executive Officer at EMV CapitalEyal NivManaging Partner | First at Pitango
.png)
+ 64 more
Shared employers
Also worked at AtaiBeckley9
Robert HershbergSenior Advisor at Frazier Life SciencesSrinivas RaoCo-Founder and Chief Executive Officer at atai Life SciencesGerd KochendoerferChief Operating Officer at atai Life SciencesAnne JohnsonChief Accounting Officer at atai Life SciencesScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesLaurent FischerDirector at atai Life Sciences
+ 3 more
Also worked at Jazz Pharmaceuticals2
Also worked at Singapore-MIT Alliance for Research & Technology Innovation Center7
Dr. Virginia ChaVenture Partner at iGlobe PartnersGerard ChiaPartner at Clay CapitalMenno van der ZeeInvestor at Volve CapitalVishal HarnalGlobal Managing Partner; Managing Partner, Southeast Asia at 500 Startups VietnamAdit AbrahamFounder at ReductoMax RavenFounder at Interface
+ 1 more
Also worked at NHS37
Francois PrinslooInvestor at MedicxiShahzad MalikGeneral Partner at Advent Life SciencesSvetlana KingFinancial Planning and Analysis Manager at EMV CapitalElaine HegartyChief of Staff at IQ CapitalAndrew ElderDeputy Managing Partner at AlbionVCRosie BarnettPrincipal at Delin Ventures
+ 31 more